廖国阳，研究员，博士研究生导师，疫苗研发首席科学家，中国医学科学院医学生物学研究所病毒疫苗研究中心主任。曾获得云南省科技进步特等奖。获得国家重大专项和Bill-Melinda Gates基金等项目资助。

长期从事疫苗生产工艺研究和新产品研发，研发全球首个Sabin株脊髓灰质炎灭活疫苗（Sabin IPV）获1类新药证书、生产文号和上市。冻干Hib结合疫苗进入PreIND申报，四价流感病毒裂解疫苗已获得四价流感裂解疫苗临床试验批件，并完成3期临床试验现场研究。同时，开展了多价新型冠状病毒mRNA疫苗、新冠减毒活疫苗毒株筛选和肺炎支原体疫苗探索性研究，已突破多项关键技术。已培养博士研究生15人，硕士30多人。

1.Lei Ma#, Zhifang Ying#, Wei Cai#, Jianfeng Wang, Jian Zhou, Huijuan Yang, Jingxia Gao, Zhimei Zhao, Jing Liu, Shengjie Ouyang, Shaohui Song, Fei Shen, Ruirui Zhao, Lilan Xu, Xiaohu Dai, Yanan Wu, Weidong Li*, Changgui Li*, and Guoyang Liao*. Immune persistence of an inactivated poliovirus vaccine derived from the Sabin strain: a 10-year follow-up of a phase 3 study. EClinicalMedicine 2023; 64: 102151. (IF=15.1, PIII)

2.Sun M#,Li R, Li C#,Liao G#, Li R, Zhou J, Li Y, Cai W, Yan D, Che Y, Ying Z, Wang J, Yang H, Ma Y, Ma L, Ji G, Shi L, Jiang S, Li Q*. Immune Serum From Sabin Inactivated Poliovirus Vaccine Immunization Neutralizes Multiple Individual Wild and Vaccine-Derived Polioviruses. Clin Infect Dis. 2017;64(10):1317-1325. (IF8.116)

3. Liao G#, Li R#, Li C#, Sun M#, Jiang S#, Li Y, Mo Z, Xia J, Xie Z, Che Y, Yang J, Yin Z, Wang J, Chu J, Cai W, Zhou J, Wang J, Li Q*. Phase 3 Trial of a Sabin Strain-Based Inactivated Poliovirus Vaccine. J Infect Dis. 2016;214(11):1728-1734.(6.273)

4. Liao G#, Li R#, Li C#, Sun M, Li Y, Chu J, Jiang S, Li Q*. Safety and immunogenicity of inactivated poliovirus vaccine made from Sabin strains: a phase II, randomized, positive-controlled trial. J Infect Dis. 2012;205(2):237-43. (IF5.848)

5.Liao G#, Wang Y*, Chang J, Bian T, Tan W, Sun M, Li W, Yang H, Chen J, Zhang X, Bi S, Omata M, Jiang S*. Hepatitis B virus precore protein augments genetic immunizations of the truncated hepatitis C virus core in BALB/c mice. Hepatology. 2008;47(1):25-34. (IF11.355)